Showing results (21-30 of 52) with videos related to
Sort By:
Pageof 6
Neuropsychiatric Disease and Treatment|April 10, 2013
Depressive symptoms in Parkinson's disease and in non-neurological medical illnessesFrancesca Assogna, Sabrina Fagioli, Luca Cravello, et al.Neuroscience Letters|October 15, 2018
DAT gene polymorphisms (rs28363170, rs393795) and levodopa-induced dyskinesias in Parkinson's diseaseCarlo Purcaro, Nicola Vanacore, Federica Moret, et al.Journal of the Neurological Sciences|October 25, 2016
Cardiovascular dysfunction in untreated Parkinson's disease: A multi-modality assessmentStefano Strano, Alessandra Fanciulli, Massimiliano Rizzo, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 24, 2004
Case-control study of multiple system atrophyNicola Vanacore, Vincenzo Bonifati, Giovanni Fabbrini, et al.Journal of Neurology|May 29, 2019
Motor and non-motor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel: final results of the GREENFIELD observational studyLeonardo Lopiano, Nicola Modugno, Pietro Marano, et al.Movement Disorders : Official Journal of the Movement Disorder Society|March 24, 2010
Bladder symptoms assessed with overactive bladder questionnaire in Parkinson's diseaseElisa Iacovelli, Francesca Gilio, Giuseppe Meco, et al.Annals of Neurology|February 9, 2002
Localization of autosomal recessive early-onset parkinsonism to chromosome 1p36 (PARK7) in an independent datasetVincenzo Bonifati, Guido J Breedveld, Ferdinando Squitieri, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 17, 2016
Motor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel in Italy: an interim analysis from the GREENFIELD observational studyLeonardo Lopiano, Nicola Modugno, Pietro Marano, et al.Expert Opinion on Pharmacotherapy|October 17, 2012
A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's diseaseUbaldo Bonuccelli, Giuseppe Meco, Giovanni Fabbrini, et al.Parkinsonism & Related Disorders|April 19, 2012
The validity and reliability of the Italian Olfactory Identification Test (IOIT) in healthy subjects and in Parkinson's disease patientsCarlo Maremmani, Giuseppe Rossi, Nicola Tambasco, et al.Pageof 6